UNIFYING FEATURES OF SYSTEMIC AND CEREBRAL AMYLOIDOSIS

被引:72
作者
GHISO, J [1 ]
WISNIEWSKI, T [1 ]
FRANGIONE, B [1 ]
机构
[1] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016
关键词
AMYLOID BETA; ALZHEIMERS DISEASE; PRION; CHAPERONES; APOE; APOJ;
D O I
10.1007/BF02778007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amyloidosis is a generic term for a group of clinically and biochemically diverse diseases that are characterized by the deposition of an insoluble fibrillar protein in the extracellular space. Over 16 biochemically distinct amyloids are known. Despite this diversity, all amyloids have a particular ultrastructural and tinctorial appearance, a beta-pleated sheet structure, and are codeposited with a group of amyloid-associated proteins. The most common amyloidosis is Alzheimer's disease (AD), where A beta is the main component of the amyloid. Recently it has been found that A beta exists as a normal soluble protein (sA beta) in biological fluids. This links AD more closely to some of the systemic amyloidoses, where the amyloid precursor is found in the circulation normally. Numerous mutations have been found in the A beta precursor (beta PP) gene, associated with familial AD. Many mutations are also found in some of the hereditary systemic amyloidoses. For example, over 40 mutations in the transthyretin (TTR) gene are associated with amyloid. However, both A beta and TTR related amyloid deposition can occur with no mutation. The pathogenesis of amyloid is complex, and appears to be associated with genetic and environmental risk factors that can be similar in the systemic and cerebral amyloidoses.
引用
收藏
页码:49 / 64
页数:16
相关论文
共 246 条
  • [1] Almeida Maria Do Rosario, 1993, Journal of Rheumatology, V20, P189
  • [2] ALMEIDA MR, 1990, 6TH INT S AM OSL, pA127
  • [3] ALVES IL, 1992, CLIN GENET, V42, P27
  • [4] BETA-AMYLOID PROTEIN IMMUNOREACTIVITY IN MUSCLE OF PATIENTS WITH INCLUSION-BODY MYOSITIS
    ASKANAS, V
    ENGEL, WK
    ALVAREZ, RB
    GLENNER, GG
    [J]. LANCET, 1992, 339 (8792) : 560 - 561
  • [5] Axelrad M. A., 1980, AMYLOID AMYLOIDOSIS, P527
  • [6] AXELRAD MA, 1982, LAB INVEST, V47, P139
  • [7] SYNOVIAL AMYLOIDOSIS IN PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS
    BARDIN, T
    KUNTZ, D
    ZINGRAFF, J
    VOISIN, MC
    ZELMAR, A
    LANSAMAN, J
    [J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (09): : 1052 - 1058
  • [8] THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN-C) AMONGST THE CYSTEINE PROTEINASE-INHIBITORS
    BARRETT, AJ
    DAVIES, ME
    GRUBB, A
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) : 631 - 636
  • [9] SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA
    BARROW, CJ
    YASUDA, A
    KENNY, PTM
    ZAGORSKI, MG
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) : 1075 - 1093
  • [10] AMYLOID PROTEIN SAA IS ASSOCIATED WITH HIGH-DENSITY LIPOPROTEIN FROM HUMAN-SERUM - (APOLIPOPROTEINS)
    BENDITT, EP
    ERIKSEN, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) : 4025 - 4028